EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The evolving landscape of the Warburg effect in gastric cancer: From molecular mechanisms to targeted therapy

Guanmo Liu, Pan Li, Zizhuo Li, Jie Li, Chenggang Zhang, Yihua Wang, Weiming Kang, Xin Ye

Clinical and Translational Medicine · 2026-08 · 16 (8)

DOI: 10.1002/ctm2.70772 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, online erschienen am 05.08.2026. Verfasst von Guanmo Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, Ch…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Warburg Effect, Oncologic, Molecular Targeted Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 293 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, Fundamental Research Funds for the Central Universities, Peking Union Medical College, National High Level Hospital Clinical Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastric cancer (GC) remains a major health burden because of late‐stage diagnosis and resistance to systemic therapy. Main body In GC, the Warburg effect is driven by interconnected hypoxia and oncogenic signalling, non‐coding RNA networks and transcriptional and epigenetic rewiring. These regulators converge on glucose transport and core glycolytic enzymes, including HK2, PFKFB3, PKM2 and LDHA. The resulting increase in aerobic glycolysis, pyruvate‐to‐lactate conversion and lactate export supports biosynthesis, redox homeostasis and survival under metabolic stress. Beyond its bioenergetic role, lactate acts as a signalling metabolite that acidifies and remodels the tumour microenvironment. It impairs CD8‐positive T and natural killer cells function, promotes regulatory T cells accumulation and M2 macrophages polarisation, activates stromal cells and facilitates epithelial–mesenchymal transition and immune evasion. Together, tumour‐intrinsic metabolic adaptation and lactate‐mediated microenvironmental reprogramming contribute to resistance to chemotherapy, targeted therapy and immunotherapy. Translationally, metabolic imaging, circulating LDH and lactate‐related markers, exosomal glycolytic enzymes, gene‐expression signatures and lactylation‐related features may improve prognostic assessment, treatmentresponse prediction and patient stratification. These findings support biomarker‐guided combination strategies that target tumour metabolism, lactate production or transport and stromalimmune crosstalk alongside standard therapies. This review uniquely integrates direct GC‐derived evidence with indirect evidence from non‐GC models and clinical trials and grades biomarkers and metabolic interventions according to their translational maturity.

Conclusion

Overall, the Warburg effect represents both a central driver of GC progression and a clinically relevant metabolic vulnerability. Key points The Warburg effect in gastric cancer is a multi‐module metabolic state, not a single glycolytic phenotype. Lactate links glycolytic reprogramming to stromal activation, immune evasion and therapy resistance. Microbiota, especially H. pylori , modulates glycolysis and creates actionable upstream vulnerabilities. Biomarker‐guided combinations, rather than isolated glycolytic inhibition, define the translational path forward.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsWarburg Effect, OncologicMolecular Targeted TherapyHumansTumor MicroenvironmentMetabolic Reprogramming

Stichwörter der Autor:innen

Warburg effectgastric cancerglycolysismetabolic heterogeneitytargeted therapy

Autor:innen und Institutionen

  • Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • Fundamental Research Funds for the Central Universities, Peking Union Medical College
  • National High Level Hospital Clinical Research Funding
  • Development Center for Medical Science & Technology National Health Commission of the People's Republic of China
  • CIMF-CSPEN Project Management Committee
  • Bethune Charitable Foundation
  • Peking Union Medical College Hospital Research Funding for Postdoc
  • Postdoctoral Fellowship Program of China Postdoctoral Science Foundation

Zitieren

APA

Liu, G., Li, P., Li, Z., Li, J., Zhang, C., Wang, Y., Kang, W., & Ye, X. (2026). The evolving landscape of the Warburg effect in gastric cancer: From molecular mechanisms to targeted therapy. Clinical and Translational Medicine, 16(8). https://doi.org/10.1002/ctm2.70772

Vancouver

Liu G, Li P, Li Z, Li J, Zhang C, Wang Y, et al. The evolving landscape of the Warburg effect in gastric cancer: From molecular mechanisms to targeted therapy. Clinical and Translational Medicine. 2026;16(8). doi:10.1002/ctm2.70772

BibTeX
@article{Liu2026,
  author = {Liu, Guanmo and Li, Pan and Li, Zizhuo and Li, Jie and Zhang, Chenggang and Wang, Yihua and Kang, Weiming and Ye, Xin},
  title = {The evolving landscape of the Warburg effect in gastric cancer: From molecular mechanisms to targeted therapy},
  journal = {Clinical and Translational Medicine},
  year = {2026},
  volume = {16},
  number = {8},
  doi = {10.1002/ctm2.70772}
}
Kostenlos starten →